Hemolytic uremic syndrome due to homozygous factor H deficiency

Sidharth Kumar Sethi(Medanta The Medicity), Arvind Bagga(All India Institute of Medical Sciences), Neelam Thaker(All India Institute of Medical Sciences), Marie‐Agnès Dragon‐Durey(Centre de Recherche des Cordeliers), Pankaj Hari(Indian Council of Medical Research)
Clinical and Experimental Nephrology
June 30, 2009
10.1007/s10157-009-0205-3
Cited by 10

Related Papers

Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study
|The Lancet Child & Adolescent Health|2017|722
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216